Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Boston Bio Systems Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Boston Bio Systems Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Boston Bio Systems L - Announcement under Regulation 30 (LODR)-Change of Company Name

    27 Nov 2025, 5:09PM Intimation under Regulation 30 of the SEBI (LODR) Regulation 2015 - Change in the Name of the Company.\r\n
  • Boston Bio Systems L - Considered And Approved The Standalone Un-Audited Financial Results Of The Company For The Quarter And

    14 Nov 2025, 1:43PM Unaudited Financial Results of the company for the quarter and half year ended on 30th September, 2025.
  • Boston Bio Systems L - Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligati

    14 Nov 2025, 1:37PM Outcome of Board Meeting pursuant to Regulation 30 of SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015 held today i.e. 14th Novemb
  • Boston Bio Systems L - Board Meeting Intimation for Prior Intimation Of Date Of Board Meeting For Considering The Unaudited F

    7 Nov 2025, 12:42PM Boston Bio Systems Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider a
  • Boston Bio Systems L has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025

    15 Oct 2025, 6:30PM As of September 2025, 2.14% is owned by Indian Promoters and 97.86% by Public. <p align=justify> Top Promoter holding highest number of shares of Bost
  • Boston Bio Systems L - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    14 Oct 2025, 1:57PM Compliance Certificate under Regulation 74(5) of SEBI(Depositories and Participants) Regulations, 2018 for the quarter ended 30 September, 2025
  • Boston Bio Systems L - Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th October, 2025 Regarding Change In Mana

    13 Oct 2025, 7:32PM Outcome of Board Meeting regarding change in management of the company
  • Boston Bio Systems L - Reg. 34 (1) Annual Report.

    11 Oct 2025, 6:16PM The revised annual report for the financial year 2024-25 is enclosed
  • Boston Bio Systems L - Reg. 34 (1) Annual Report.

    3 Oct 2025, 11:39AM Please Find Enclosed Herewith the Revised Annual Report for the Financial Year 2024-25 of the Company.
  • Boston Bio Systems L - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2025, 5:06PM PFA herewith the Scrutinizer Report of 30th Annual general meeting of the company
  • Boston Bio Systems L - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2025, 5:03PM Please Find Enclosed Herewith the Scrutinizer Report of 30th Annual General Meeting of the Company
  • Boston Bio Systems L - Shareholder Meeting / Postal Ballot-Outcome of AGM

    30 Sep 2025, 4:55PM Outcome of 30th Annual General Meeting held on 30th September, 2025
  • Boston Bio Systems L - Board Meeting Outcome for Outcome Of Board Meeting Held On 4Th September, 2025

    4 Sep 2025, 5:41PM Outcome of Board Meeting to held on 4th September, 2025
  • Boston Bio Systems L - Outcome Of The Board Meeting Held On 04Th September 2025

    4 Sep 2025, 5:15PM Please find enclosed the outcome of the Board Meeting

Key fundamentals

Evaluate the intrinsic value of Boston Bio Systems Ltd stock 

Name March-25 March-24 March-23 March-18 March-17
Assets 11.3464 7.318 7.4587 7.4659 7.4656
Liabilities 11.3464 7.318 7.4587 7.4659 7.4656
Equity 7.0022 7.0022 7.0022 7.0022 7.0022
Gross Profit -0.5473 -0.1407 -0.0022 0.0005 -0.0444
Net Profit -0.5473 -0.1407 -0.0022 0.0003 0.0005
Cash From Operating Activities -4.5856 0 -0.0012 0.1272 -0.0243
NPM(%) -284.31 0 0 0.04 0.1
Revenue 0.1925 0 0 0.6996 0.4873
Expenses 0.7398 0.1407 0.0022 0.6991 0.5317
ROE(%) -9.27 -2.38 -0.03 0 0

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Boston Bio Systems Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 794.50 -0.51 0.00 3.78 301.39 0.63
Lotus Eye Hospital and Institute Ltd 107.40 2.73 328.44 13.79 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 20.11 -0.69 0.00 28.63 -39.50 0.00
Astec Lifesciences Ltd 814.35 -3.24 0.00 13.00 -604.77 0.00

Company Info

Boston Bio Systems Ltd started as ADHAYATMDEEP EYE FOUNDATION LIMITED in April, 1995 from Amhedabad. The company focused on laser eye care industry and changed the name as LASER EYE CARE LIMITED. Having duly passed the necessary resolution in terms of section 21/31/44 of the companies act. 1956 on 22/04/2002 and the approval of the central government signifies in writing having been accorded thereto by the register of companies. Gujarat vide his letter dated 15/05/2002 in terms of Government of india. Ministry of law justice & company affairs development of company affaires notification no. GSK 50/(E) dated 24/06/1985 the name of the said company is this dav changed to BOSTON BIO SYSTEMS LIMITED.

Boston Bio Systems Ltd started as ADHAYATMDEEP EYE FOUNDATION LIMITED in April, 1995 from Amhedabad. The company focused on laser eye care industry and changed the name as LASER EYE CARE LIMITED. Having duly passed the necessary resolution in terms of section 21/31/44 of the companies act. 1956 on 22/04/2002 and the approval of the central government signifies in writing having been accorded thereto by the register of companies. Gujarat vide his letter dated 15/05/2002 in terms of Government of india. Ministry of law justice & company affairs development of company affaires notification no. GSK 50/(E) dated 24/06/1985 the name of the said company is this dav changed to BOSTON BIO SYSTEMS LIMITED.

Read More

Parent Organisation

Boston Bio Systems Ltd.

Founded

17/04/1995

Managing Director

Mr.Ghanshyam Dhananjay Gavali

NSE Symbol

FAQ

The current price of Boston Bio Systems Ltd is

The 52-week high for Boston Bio Systems Ltd is

The market capitalization of Boston Bio Systems Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Boston Bio Systems Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Boston Bio Systems Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Boston Bio Systems Ltd shares.

The CEO of Boston Bio Systems Ltd is Mr.Ghanshyam Dhananjay Gavali, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT